{"product_id":"tirz3patid4-20mg","title":"Tirz3patid4 20Mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTIRZEPATIDE — Dual GIP \u0026amp; GLP-1 Receptor Agonist\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAdvanced Metabolic Research | Glucose Regulation | Weight Management\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTirzepatide is a synthetic peptide and dual receptor agonist that simultaneously activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDeveloped by Eli Lilly and commercially available as \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eMounjaro®\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, tirzepatide is an approved once-weekly injectable prescription medicine used for the management of type 2 diabetes and, in eligible adults, obesity or overweight accompanied by weight-related health conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIts dual-action mechanism has attracted significant scientific interest due to its effects on appetite regulation, glucose metabolism, insulin secretion, and body weight.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eMechanism of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eTirzepatide acts through two complementary metabolic pathways:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGIP Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Enhances glucose-dependent insulin secretion and contributes to metabolic regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGLP-1 Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Promotes satiety, reduces appetite, supports insulin secretion, and influences gastric emptying.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGlucose Homeostasis:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Helps regulate blood glucose levels through glucose-dependent hormonal mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBody Weight Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Reduced appetite and energy intake can contribute to substantial weight reduction in eligible patients.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eClinical Research \u0026amp; Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eClinical studies have demonstrated significant improvements in glycemic control and body weight among studied populations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKey research areas include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eType 2 Diabetes:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation and clinical management of blood glucose regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eObesity and Weight Management:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Evaluation of body weight reduction and long-term weight maintenance.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAppetite Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Examination of incretin-related signaling pathways involved in hunger and satiety.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Health:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research into insulin sensitivity, energy balance, and cardiometabolic risk factors.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eRegulatory Status \u0026amp; Safety\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTirzepatide is an approved prescription medicine in the European Union, including Portugal, for specific clinical indications.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eApproved medicinal products are subject to pharmaceutical manufacturing standards, quality controls, and regulatory oversight.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCommon adverse reactions include nausea, diarrhea, vomiting, constipation, and other gastrointestinal symptoms. More serious risks and precautions are described in the official prescribing information.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe safety, purity, and effectiveness of independently manufactured or research-labeled tirzepatide preparations cannot be assumed to be equivalent to those of approved medicines.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR LEGITIMATE SCIENTIFIC AND LABORATORY RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch materials are intended exclusively for qualified professionals conducting authorized scientific investigations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eResearch-labeled preparations are not approved medicinal products and must not be used for human or veterinary administration, personal injection, or self-medication.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eA “Research Use Only” designation does not override pharmaceutical regulations or authorize the commercial supply of an unapproved injectable medicine for human use.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59502020821256,"sku":null,"price":250.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/tirz3patid4-20mg","provider":"peptitan","version":"1.0","type":"link"}